Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anemia
aneurysm, intracranial
anorexia
arrhythmia, cardiac
aspartate aminotransferase
autoantibodies
behavioral disorder
belligerent
brain natriuretic peptide
BUN, elevated
cancer associated hypercoagulation
carcinoma
carcinoma of lung
cardiomyopathy
CAT scan, chest
CAT scan, emission, abnormal
central nervous system, infection of
cerebral arteries
cerebral vasculature
cerebrospinal fluid, elevated protein of
cerebrovascular accident
cerebrovascular accident, bilateral
cerebrovascular accident, multiple
cerebrovascular accident, three territory involvement
cerebrovascular disease
chest x-ray, abnormal
Clinical Pathologic Conference(C.P.C.)
complications
confusion
cough
C-reactive protein, elevated
creatine phosphokinase(CPK)elevated
D-dimer
diabetes mellitus
diarrhea
digitalis
digitalis intoxication
disorientation
disseminated intravascular coagulation(DIC)
drug induced neurologic disorders
dysphagia
dyspnea
echocardiogram
echocardiogram, transesophageal
edema, leg
ejection fraction, abnormal
electromyogram
endemic area
endocarditis
endocarditis, marantic
falling
fatigue
fever
fibrillations
headache
heart wall motion dysfunction
hematochezia
HMGcoA reductase inhibitors
hydrocephalus
hypercoagulable state
hypoglycorrhachia
iatrogenic neurologic disorders
lethargy
leukocytosis
liver function enzymes
malaise
meningitis
meningitis, neutrophilic
meningitis, TB
mental status, abnormal
mortality
MRI, abnormal
MRI, angiography
multiple organ infarct
muscle biopsy
muscle pain
myopathy
myopathy, drug-induced
myopathy, necrotizing, autoimmune
nausea and vomiting
night sweats
non-dominant hemisphere
pleocytosis of cerebrospinal fluid
pleural effusion
pneumonia
prognosis
pulmonary embolism
renal failure
renal infarct
respiratory tract infection
rhabdomyolysis
seizure
serum alanine aminotransferase
sex reassignment surgery
somnolence
splenic infarcts
statin therapy
subarachnoid hemorrhage
subarachnoid hemorrhage, prognosis
Takotsubo cardiomyopathy
Three territory sign
transgender
treatment of neurologic disorder
troponin T
urine, dark
vasculitides
walking, difficulty with
weakness
weakness, generalized
weakness, progressive
weakness, proximal
weight loss
Showing articles 0 to 42 of 42

Clinicopathologic Conference, Mycobacterium Tuberculosis Meningitis
NEJM 384:166-176, Case 1-2021, 2021

Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019

Clinicopathologic Conference, Digitalis Toxicity
NEJM 378:1931-1938, Case 15-2018, 2018

Clinicopathologic Conference, Pulmonary Adenocarcinoma, Complicated by a Hypercoagulable State with a Nonbacterial Thrombotic Endocarditis
NEJM, Case 33-2018, 2018

Clinical Outcomes after Neurogenic Stress Induced Cardiomyopathy in Aneurysmal Sub-Arachnoid Hemorrhage: A Prospective Cohort Study
Clin Neurol Neurosurg 128:4-9, Kilbourn, K.J.,et al, 2015

Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023

Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021

Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021

One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020

Migraine
NEJM 383:1866-1876, Ashina, M., 2020

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019

Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019

Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019

Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019

Preventive Migraine Drug Approved
JAMA 320:1746, , 2018

Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018

Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018

CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017

New Drugs in Migraine Treatment and Prophylaxis: Telcagepant and Topiramate
Lancet 376:645-655, Edvinsson,L. &Linde,M., 2010

Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996

Serum Cortisol and Cerebrospinal Fluid B-Endorphins in Status Epilepticus:Their Possible Relation to Prognosis
Arch Neurol 50:689-693, Calabrese,V.P.,et al, 1993

Effect of Calcitonin-Gene-Related Peptide in Pts with Delayed Postop Cerebral Ischaemia after Aneurysmal SAH
Europ CGRP Study Group, Lancet 339:831-8341992., , 1992

Effect of Calcitonin-Gene-Related Peptide on Postoperative Neurological Deficits after Subarachnoid Haemorrhage
Lancet 335:869-872, Johnston,F.G.,et al, 1990

Vasoactive Peptide Release in the Extracerebral Circulation of Humans During Migraine Headache
Ann Neurol 28:183-187, Goadsby,P.J.,et al, 1990

Huntington's Disease, Pathogenesis & Management
NEJM 315:1267-1276, Martin,J.B.&Gusella,J.F., 1986

Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986

Effects of Naloxone in Senile Dementia:A Double-Blind Trial
NEJM 308:721-722, Reisberg,B.,et al, 1983

Acupuncture Relief of Chronic Pain Syndrome Correlates with Increased Plasma Met-Enkephalin Concentra
Lancet 2:1394-1396, Kiser,R.S.,et al, 1983

Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982

Cerebrospinal Fluid:A Selective Review
Ann Neurol 11; 1-101982., Cutler,R.W.P.,et al, 1982

How Does Acupuncture Work? Editorial
BMJ 283:746-748, , 1981

Thyrotropin-Releasing Hormone Improves Neurologic Recovery After Spinal Trauma In Cats
NEJM 305:1063-1067, Faden,A.I.,et al, 1981

Acupuncture Treatments for Pain Relief
JAMA 245:768-769, Ulett,G.A., 1981

Pain II:New Approaches to Management
Ann Neurol 9:101-106, Fields,H.L., 1981

Brain Peptides
(part I & II) NEJM 304:876-885, 944-951., Krieger,D.T.&Martin,J.G., 1981

Neuroendocrinology & Brain Peptides
Ann Neurol 8:551-557, Cooper,P.E.,et al, 1980

Opiate Peptides
Analgesia, & the Neuroendocrine System, Editorial, BMJ 1:741-742., , 1980

Hyper-Endorphin Syndrome in a Child With Necrotizing Encephalomyelopathy
NEJM 303:914-916, Brandt,N.J.,et al, 1980

Cortical Evoked Responses & Transcutaneous Electrotherapy
Neurol 30:663-665, Salar,G.,et al, 1980

Pain Sensitivity In Schizophrenics
NEJM 301:946-947, Hoo,J.J.,et al, 1979

Opiate Receptors in the Brain
NEJM 296:266, Snyder,S.H., 1977



Showing articles 0 to 42 of 42